Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion type Assertion NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_head.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion description "[Therapeutic administration of IFN-? in clinical trials significantly reduced HIV-1 plasma viral load and human T-lymphotropic virus type I proviral load in infected patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_provenance.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion evidence source_evidence_literature NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_provenance.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion SIO_000772 23315078 NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_provenance.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion wasDerivedFrom befree-2016 NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_provenance.
- NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_assertion wasGeneratedBy ECO_0000203 NP1043274.RAKj-35zEuGI-cvvBwBzmkmMxT_rnebTBe9lb32J-F0p4130_provenance.